This site uses cookies to ensure you get the best experience. Learn more

Sign up to follow your favorite podcasts and listen to episodes!

Risk, reward and the AstraZeneca vaccine

Today in Focus

20min
People in the UK under 30 will be offered an alternative to the AstraZeneca vaccine because of a possible link to rare blood clots. Could the move dent confidence in the widely used jab?. Help support our independent journalism at theguardian.com/infocus

Disclaimer: the content and artwork of this podcast are the property of its owner and are not affiliated with nor endorsed by Audiotrails.